Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial - Archive ouverte HAL Access content directly
Journal Articles Lancet Oncology Year : 2015

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Antoine Thyss
  • Function : Author
Florence Duffaud
  • Function : Author
Not file

Dates and versions

hal-03623745 , version 1 (29-03-2022)

Identifiers

Cite

Patricia Pautier, Anne Floquet, Christine Chevreau, Nicolas Penel, Cécile Guillemet, et al.. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial. Lancet Oncology, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩. ⟨hal-03623745⟩
27 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More